Drugs / GSK3277510A
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02177734 | Mar → Jun 2016 | influenza | GlaxoSmithKline | Withdrawn | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GSK3277510A | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02177734 ↗ |
| Modality | Vaccine | “GSK3277510A H7N9 vaccine” NCT02177734 ↗ |
| Route | Intramuscular | “administered intramuscularly (IM)” NCT02177734 ↗ |